Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO studySean H. Lim, David Goldblatt, Nicola Campbell et al.|Nature Cancer|2022Cited by 91
Predicting COVID-19 infection risk in people who are immunocompromised by antibody testingRatna Sari Wijaya, Sean H. Lim, Marina Johnson et al.|The Lancet|2023Cited by 16